Back to Search Start Over

Effect of oral non-peptide GLP-1 receptor agonist orforglipron (LY3502970) in participants with obesity or overweight: A Phase 2 study.

Authors :
Wharton, Sean
Blevins, Thomas
Connery, Lisa
Rosenstock, Julio
Raha, Sohini
Mather, Kieren J.
Haupt, Axel
Robins, Deborah
Pratt, Edward
Kazda, Christof
Konig, Manige
Forst, Thomas
Source :
Diabetologie und Stoffwechsel; 2024 Supplement, Vol. 19, pS83-S83, 1p
Publication Year :
2024

Details

Language :
German
ISSN :
18619002
Volume :
19
Database :
Complementary Index
Journal :
Diabetologie und Stoffwechsel
Publication Type :
Academic Journal
Accession number :
176743082
Full Text :
https://doi.org/10.1055/s-0044-1785400